<div class="headers"><div>Figure <U+F63B>. Forest plot of the treatment di<U+FB00>erence in trough FEV<U+F6DC> (L) at Week <U+F63A><U+F63E> across di<U+FB00>erent subgroups of the LANTERN study. IND/GLY, indacaterol/glycopyrronium. SFC, salmeterol/<U+FB02>uticasone</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<thead>
<tr>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey;'> </th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>row/col</th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>6(F)</th>
</tr>
</thead>
<tbody>
<tr>
<td style='border-bottom: 2px solid grey; text-align: left;'>1</td>
<td style='border-bottom: 2px solid grey; text-align: left;'>1</td>
<td style='border-bottom: 2px solid grey; text-align: left;'><p class="">Figure <U+F63B>. Forest plot of the treatment di<U+FB00>erence in trough FEV<U+F6DC> (L) at Week <U+F63A><U+F63E> across di<U+FB00>erent subgroups of the LANTERN study. IND/GLY, indacaterol/glycopyrronium. SFC, salmeterol/<U+FB02>uticasone</p></td>
</tr>
</tbody>
</table>
